<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36555685</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>24</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>16</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Connexin 30 Deficiency Ameliorates Disease Progression at the Early Phase in a Mouse Model of Amyotrophic Lateral Sclerosis by Suppressing Glial Inflammation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">16046</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms232416046</ELocationID><Abstract><AbstractText>Connexin 30 (Cx30), which forms gap junctions between astrocytes, regulates cell adhesion and migration, and modulates glutamate transport. Cx30 is upregulated on activated astroglia in central nervous system inflammatory lesions, including spinal cord lesions in mutant superoxide dismutase 1 (mSOD1) transgenic amyotrophic lateral sclerosis (ALS) model mice. Here, we investigated the role of Cx30 in mSOD1 mice. Cx30 was highly expressed in the pre-onset stage in mSOD1 mice. mSOD1 mice with knockout (KO) of the <i>Cx30</i> gene (<i>Cx30</i>KO-mSOD1 mice) showed delayed disease onset and tended to have an extended survival period (log-rank, <i>p</i> = 0.09). At the progressive and end stages of the disease, anterior horn cells were significantly preserved in <i>Cx30</i>KO-mSOD1 mice. In lesions of these mice, glial fibrillary acidic protein/C3-positive inflammatory astroglia were decreased. Additionally, the activation of astrocytes in <i>Cx30</i>KO-mSOD1 mice was reduced compared with mSOD1 mice by gene expression microarray. Furthermore, expression of connexin 43 at the pre-onset stage was downregulated in <i>Cx30</i>KO-mSOD1 mice. These findings suggest that reduced expression of astroglial Cx30 at the early disease stage in ALS model mice protects neurons by attenuating astroglial inflammation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hashimoto</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamasaki</LastName><ForeName>Ryo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Senri</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuo</LastName><ForeName>Eriko</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kobayakawa</LastName><ForeName>Yuko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masaki</LastName><ForeName>Katsuhisa</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuse</LastName><ForeName>Dai</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isobe</LastName><ForeName>Noriko</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-9525-4254</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>JP16K09694</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country/></Grant><Grant><GrantID>JP19K07963</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country/></Grant><Grant><GrantID>FAJJ040507</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant><Grant><GrantID>JPMH20FC2004</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country/></Grant><Grant><GrantID>JP21zf0127004</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000075302">Connexin 30</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C100629">Gjb6 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000075302" MajorTopicYN="Y">Connexin 30</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">SOD1</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">astrocytes</Keyword><Keyword MajorTopicYN="N">connexin 30</Keyword><Keyword MajorTopicYN="N">mSOD1 mice</Keyword></KeywordList><CoiStatement>R.Y. has received honoraria from Teijin Pharma, Ono Pharmaceutical, Takeda Pharmaceutical, Eisai, Novartis, Nihon Pharmaceutical, and CSL Behring.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>23</Day><Hour>1</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36555685</ArticleId><ArticleId IdType="pmc">PMC9782489</ArticleId><ArticleId IdType="doi">10.3390/ijms232416046</ArticleId><ArticleId IdType="pii">ijms232416046</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowland L.P., Shneider N.A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland D.W., Rothstein J.D. From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2001;2:806&#x2013;819. doi: 10.1038/35097565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35097565</ArticleId><ArticleId IdType="pubmed">11715057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley W.G. Updates on amyotrophic lateral sclerosis: Improving patient care. Ann. Neurol. 2009;65((Suppl. S1)):S1&#x2013;S2. doi: 10.1002/ana.21546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21546</ArticleId><ArticleId IdType="pubmed">19191303</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W.Y., Getzoff E.D., Hu P., Herzfeldt B., Roos R.P., et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science. 1993;261:1047&#x2013;1051. doi: 10.1126/science.8351519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8351519</ArticleId><ArticleId IdType="pubmed">8351519</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z.Y., Zhou Z.R., Che C.H., Liu C.Y., He R.L., Huang H.P. Genetic epidemiology of amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2017;88:540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chi&#xf2; A., Traynor B.J. Novel genes associated with amyotrophic lateral sclerosis: Diagnostic and clinical implications. Lancet Neurol. 2018;17:94&#x2013;102. doi: 10.1016/S1474-4422(17)30401-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H., Polymenidou M., Cleveland D.W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 2009;187:761&#x2013;772. doi: 10.1083/jcb.200908164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Komine O. The multi-dimensional roles of astrocytes in ALS. Neurosci. Res. 2018;126:31&#x2013;38. doi: 10.1016/j.neures.2017.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2017.09.011</ArticleId><ArticleId IdType="pubmed">29054467</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Hyeon S.J., Im H., Ryu H., Kim Y., Ryu H. Astrocytes and Microglia as Non-cell Autonomous Players in the Pathogenesis of ALS. Exp. Neurobiol. 2016;25:233&#x2013;240. doi: 10.5607/en.2016.25.5.233.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2016.25.5.233</ArticleId><ArticleId IdType="pmc">PMC5081469</ArticleId><ArticleId IdType="pubmed">27790057</ArticleId></ArticleIdList></Reference><Reference><Citation>Pramatarova A., Lagani&#xe8;re J., Roussel J., Brisebois K., Rouleau G.A. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J. Neurosci. 2001;21:3369&#x2013;3374. doi: 10.1523/JNEUROSCI.21-10-03369.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-10-03369.2001</ArticleId><ArticleId IdType="pmc">PMC6762496</ArticleId><ArticleId IdType="pubmed">11331366</ArticleId></ArticleIdList></Reference><Reference><Citation>Lino M.M., Schneider C., Caroni P. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J. Neurosci. 2002;22:4825&#x2013;4832. doi: 10.1523/JNEUROSCI.22-12-04825.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-12-04825.2002</ArticleId><ArticleId IdType="pmc">PMC6757755</ArticleId><ArticleId IdType="pubmed">12077179</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Y.H., Parsadanian A.S., Andreeva A., Snider W.D., Elliott J.L. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J. Neurosci. 2000;20:660&#x2013;665. doi: 10.1523/JNEUROSCI.20-02-00660.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-02-00660.2000</ArticleId><ArticleId IdType="pmc">PMC6772423</ArticleId><ArticleId IdType="pubmed">10632595</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boill&#xe9;e S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science. 2003;302:113&#x2013;117. doi: 10.1126/science.1086071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1086071</ArticleId><ArticleId IdType="pubmed">14526083</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., Cleveland D.W. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 2008;11:251&#x2013;253. doi: 10.1038/nn2047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Gutmann D.H., Roos R.P. Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice. Hum. Mol. Genet. 2011;20:286&#x2013;293. doi: 10.1093/hmg/ddq463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq463</ArticleId><ArticleId IdType="pubmed">20962037</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M., Re D.B., Nagata T., Chalazonitis A., Jessell T.M., Wichterle H., Przedborski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 2007;10:615&#x2013;622. doi: 10.1038/nn1876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1876</ArticleId><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra P.S., Dhull D.K., Nalini A., Vijayalakshmi K., Sathyaprabha T.N., Alladi P.A., Raju T.R. Astroglia acquires a toxic neuroinflammatory role in response to the cerebrospinal fluid from amyotrophic lateral sclerosis patients. J. Neuroinflamm. 2016;13:212. doi: 10.1186/s12974-016-0698-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0698-0</ArticleId><ArticleId IdType="pmc">PMC5006495</ArticleId><ArticleId IdType="pubmed">27578023</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi P., Rodriguez-Muela N., Klim J.R., de Boer A.S., Agrawal S., Sandoe J., Lopes C.S., Ogliari K.S., Williams L.A., Shear M., et al. Reactive Astrocytes Promote ALS-like Degeneration and Intracellular Protein Aggregation in Human Motor Neurons by Disrupting Autophagy through TGF-beta1. Stem Cell Rep. 2017;9:667&#x2013;680. doi: 10.1016/j.stemcr.2017.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.06.008</ArticleId><ArticleId IdType="pmc">PMC5549875</ArticleId><ArticleId IdType="pubmed">28712846</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Z.C., Wyeth M.S., Baltan-Tekkok S., Ransom B.R. Functional hemichannels in astrocytes: A novel mechanism of glutamate release. J. Neurosci. 2003;23:3588&#x2013;3596. doi: 10.1523/JNEUROSCI.23-09-03588.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-09-03588.2003</ArticleId><ArticleId IdType="pmc">PMC6742182</ArticleId><ArticleId IdType="pubmed">12736329</ArticleId></ArticleIdList></Reference><Reference><Citation>Santello M., Toni N., Volterra A. Astrocyte function from information processing to cognition and cognitive impairment. Nat. Neurosci. 2019;22:154&#x2013;166. doi: 10.1038/s41593-018-0325-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0325-8</ArticleId><ArticleId IdType="pubmed">30664773</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X., Su Y., Wang N., Li H., Li Z., Yin G., Chen H., Niu J., Yi C. Astroglial Connexins in Neurodegenerative Diseases. Front Mol. Neurosci. 2021;14:657514. doi: 10.3389/fnmol.2021.657514.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2021.657514</ArticleId><ArticleId IdType="pmc">PMC8192976</ArticleId><ArticleId IdType="pubmed">34122008</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Campenhout R., Gomes A.R., De Groof T.W.M., Muyldermans S., Devoogdt N., Vinken M. Mechanisms Underlying Connexin Hemichannel Activation in Disease. Int. J. Mol. Sci. 2021;22:3503. doi: 10.3390/ijms22073503.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22073503</ArticleId><ArticleId IdType="pmc">PMC8036530</ArticleId><ArticleId IdType="pubmed">33800706</ArticleId></ArticleIdList></Reference><Reference><Citation>Willebrords J., Crespo Yanguas S., Maes M., Decrock E., Wang N., Leybaert L., Kwak B.R., Green C.R., Cogliati B., Vinken M. Connexins and their channels in inflammation. Crit. Rev. Biochem. Mol. Biol. 2016;51:413&#x2013;439. doi: 10.1080/10409238.2016.1204980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10409238.2016.1204980</ArticleId><ArticleId IdType="pmc">PMC5584657</ArticleId><ArticleId IdType="pubmed">27387655</ArticleId></ArticleIdList></Reference><Reference><Citation>Decrock E., Vinken M., De Vuyst E., Krysko D.V., D&#x2019;Herde K., Vanhaecke T., Vandenabeele P., Rogiers V., Leybaert L. Connexin-related signaling in cell death: To live or let die? Cell Death Differ. 2009;16:524&#x2013;536. doi: 10.1038/cdd.2008.196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2008.196</ArticleId><ArticleId IdType="pubmed">19197295</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi J., Li L., Liu M., Tan J., Tang C., Pan Q., Wang D., Zhang Z. Pathogenic connexin-31 forms constitutively active hemichannels to promote necrotic cell death. PLoS ONE. 2012;7:e32531. doi: 10.1371/journal.pone.0032531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0032531</ArticleId><ArticleId IdType="pmc">PMC3290583</ArticleId><ArticleId IdType="pubmed">22393412</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez W., Ramachandran J., Alsamarah A., Luo Y., Harris A.L., Contreras J.E. Mechanism of gating by calcium in connexin hemichannels. Proc. Natl. Acad. Sci. USA. 2016;113:E7986&#x2013;E7995. doi: 10.1073/pnas.1609378113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1609378113</ArticleId><ArticleId IdType="pmc">PMC5150374</ArticleId><ArticleId IdType="pubmed">27872296</ArticleId></ArticleIdList></Reference><Reference><Citation>Rash J.E., Yasumura T., Davidson K.G., Furman C.S., Dudek F.E., Nagy J.I. Identification of cells expressing Cx43, Cx30, Cx26, Cx32 and Cx36 in gap junctions of rat brain and spinal cord. Cell Commun. Adhes. 2001;8:315&#x2013;320. doi: 10.3109/15419060109080745.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/15419060109080745</ArticleId><ArticleId IdType="pmc">PMC1805789</ArticleId><ArticleId IdType="pubmed">12064610</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosejacob D., Dublin P., Bedner P., Huttmann K., Zhang J., Tress O., Willecke K., Pfrieger F., Steinhauser C., Theis M. Role of astroglial connexin30 in hippocampal gap junction coupling. Glia. 2011;59:511&#x2013;519. doi: 10.1002/glia.21120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.21120</ArticleId><ArticleId IdType="pubmed">21264956</ArticleId></ArticleIdList></Reference><Reference><Citation>Pannasch U., Vargova L., Reingruber J., Ezan P., Holcman D., Giaume C., Sykova E., Rouach N. Astroglial networks scale synaptic activity and plasticity. Proc. Natl. Acad. Sci. USA. 2011;108:8467&#x2013;8472. doi: 10.1073/pnas.1016650108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1016650108</ArticleId><ArticleId IdType="pmc">PMC3100942</ArticleId><ArticleId IdType="pubmed">21536893</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J.H., Takano T., Cotrina M.L., Arcuino G., Kang J., Liu S., Gao Q., Jiang L., Li F., Lichtenberg-Frate H., et al. Connexin 43 enhances the adhesivity and mediates the invasion of malignant glioma cells. J. Neurosci. 2002;22:4302&#x2013;4311. doi: 10.1523/JNEUROSCI.22-11-04302.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-11-04302.2002</ArticleId><ArticleId IdType="pmc">PMC6758793</ArticleId><ArticleId IdType="pubmed">12040035</ArticleId></ArticleIdList></Reference><Reference><Citation>Elias L.A., Wang D.D., Kriegstein A.R. Gap junction adhesion is necessary for radial migration in the neocortex. Nature. 2007;448:901&#x2013;907. doi: 10.1038/nature06063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06063</ArticleId><ArticleId IdType="pubmed">17713529</ArticleId></ArticleIdList></Reference><Reference><Citation>Plotkin L.I. Connexin 43 hemichannels and intracellular signaling in bone cells. Front Physiol. 2014;5:131. doi: 10.3389/fphys.2014.00131.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2014.00131</ArticleId><ArticleId IdType="pmc">PMC3983496</ArticleId><ArticleId IdType="pubmed">24772090</ArticleId></ArticleIdList></Reference><Reference><Citation>Pannasch U., Freche D., Dallerac G., Ghezali G., Escartin C., Ezan P., Cohen-Salmon M., Benchenane K., Abudara V., Dufour A., et al. Connexin 30 sets synaptic strength by controlling astroglial synapse invasion. Nat. Neurosci. 2014;17:549&#x2013;558. doi: 10.1038/nn.3662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3662</ArticleId><ArticleId IdType="pubmed">24584052</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghezali G., Dallerac G., Rouach N. Perisynaptic astroglial processes: Dynamic processors of neuronal information. Brain Struct. Funct. 2016;221:2427&#x2013;2442. doi: 10.1007/s00429-015-1070-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00429-015-1070-3</ArticleId><ArticleId IdType="pubmed">26026482</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy E., Cohen-Salmon M., Rouach N., Rancillac A. Astroglial Cx30 differentially impacts synaptic activity from hippocampal principal cells and interneurons. Glia. 2021;69:2178&#x2013;2198. doi: 10.1002/glia.24017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.24017</ArticleId><ArticleId IdType="pubmed">33973274</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu C., Gardner P., Schrijver I. The role of the cytoskeleton in the formation of gap junctions by Connexin 30. Exp. Cell Res. 2009;315:1683&#x2013;1692. doi: 10.1016/j.yexcr.2009.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2009.03.001</ArticleId><ArticleId IdType="pubmed">19285977</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez O.F., Rodriguez A.V., Velasco-Espana J.M., Murillo L.C., Sutachan J.J., Albarracin S.L. Role of Connexins 30, 36, and 43 in Brain Tumors, Neurodegenerative Diseases, and Neuroprotection. Cells. 2020;9:846. doi: 10.3390/cells9040846.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9040846</ArticleId><ArticleId IdType="pmc">PMC7226843</ArticleId><ArticleId IdType="pubmed">32244528</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y., Masaki K., Yamasaki R., Imamura S., Suzuki S.O., Hayashi S., Sato S., Nagara Y., Kawamura M.F., Kira J. Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model. J. Neuroinflamm. 2014;11:42. doi: 10.1186/1742-2094-11-42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-42</ArticleId><ArticleId IdType="pmc">PMC4016493</ArticleId><ArticleId IdType="pubmed">24597481</ArticleId></ArticleIdList></Reference><Reference><Citation>Almad A.A., Doreswamy A., Gross S.K., Richard J.P., Huo Y., Haughey N., Maragakis N.J. Connexin 43 in astrocytes contributes to motor neuron toxicity in amyotrophic lateral sclerosis. Glia. 2016;64:1154&#x2013;1169. doi: 10.1002/glia.22989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22989</ArticleId><ArticleId IdType="pmc">PMC5635605</ArticleId><ArticleId IdType="pubmed">27083773</ArticleId></ArticleIdList></Reference><Reference><Citation>Almad A.A., Taga A., Joseph J., Gross S.K., Welsh C., Patankar A., Richard J.P., Rust K., Pokharel A., Plott C., et al. Cx43 hemichannels contribute to astrocyte-mediated toxicity in sporadic and familial ALS. Proc. Natl. Acad. Sci. USA. 2022;119:e2107391119. doi: 10.1073/pnas.2107391119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2107391119</ArticleId><ArticleId IdType="pmc">PMC9060483</ArticleId><ArticleId IdType="pubmed">35312356</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayakawa Y., Masaki K., Yamasaki R., Shiraishi W., Hayashida S., Hayashi S., Okamoto K., Matsushita T., Kira J.I. Downregulation of Neuronal and Dendritic Connexin36-Made Electrical Synapses Without Glutamatergic Axon Terminals in Spinal Anterior Horn Cells From the Early Stage of Amyotrophic Lateral Sclerosis. Front Neurosci. 2018;12:894. doi: 10.3389/fnins.2018.00894.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00894</ArticleId><ArticleId IdType="pmc">PMC6279874</ArticleId><ArticleId IdType="pubmed">30546295</ArticleId></ArticleIdList></Reference><Reference><Citation>Belousov A.B., Nishimune H., Denisova J.V., Fontes J.D. A potential role for neuronal connexin 36 in the pathogenesis of amyotrophic lateral sclerosis. Neurosci. Lett. 2018;666:1&#x2013;4. doi: 10.1016/j.neulet.2017.12.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.12.027</ArticleId><ArticleId IdType="pmc">PMC5805564</ArticleId><ArticleId IdType="pubmed">29246791</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamanian J.L., Xu L., Foo L.C., Nouri N., Zhou L., Giffard R.G., Barres B.A. Genomic analysis of reactive astrogliosis. J. Neurosci. 2012;32:6391&#x2013;6410. doi: 10.1523/JNEUROSCI.6221-11.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.6221-11.2012</ArticleId><ArticleId IdType="pmc">PMC3480225</ArticleId><ArticleId IdType="pubmed">22553043</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S.A., Guttenplan K.A., Clarke L.E., Bennett F.C., Bohlen C.J., Schirmer L., Bennett M.L., Munch A.E., Chung W.S., Peterson T.C., et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481&#x2013;487. doi: 10.1038/nature21029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Escartin C., Galea E., Lakatos A., O&#x2019;Callaghan J.P., Petzold G.C., Serrano-Pozo A., Steinhauser C., Volterra A., Carmignoto G., Agarwal A., et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat. Neurosci. 2021;24:312&#x2013;325. doi: 10.1038/s41593-020-00783-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00783-4</ArticleId><ArticleId IdType="pmc">PMC8007081</ArticleId><ArticleId IdType="pubmed">33589835</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamasaki R. Novel animal model of multiple sclerosis: The glial connexin gap junction as an environmental tuner for neuroinflammation. Clin. Exp. Neuroimmunol. 2020;11:34&#x2013;40. doi: 10.1111/cen3.12568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen3.12568</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang M., Yamasaki R., Li G., Masaki K., Yamaguchi H., Fujita A., Isobe N., Kira J.I. Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia. Front Immunol. 2018;9:2588. doi: 10.3389/fimmu.2018.02588.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02588</ArticleId><ArticleId IdType="pmc">PMC6234958</ArticleId><ArticleId IdType="pubmed">30464764</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroner A., Greenhalgh A.D., Zarruk J.G., Passos Dos Santos R., Gaestel M., David S. TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord. Neuron. 2014;83:1098&#x2013;1116. doi: 10.1016/j.neuron.2014.07.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.07.027</ArticleId><ArticleId IdType="pubmed">25132469</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei X., Ezan P., Giaume C., Koulakoff A. Astroglial connexin immunoreactivity is specifically altered at beta-amyloid plaques in beta-amyloid precursor protein/presenilin1 mice. Neuroscience. 2010;171:92&#x2013;105. doi: 10.1016/j.neuroscience.2010.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2010.08.001</ArticleId><ArticleId IdType="pubmed">20813165</ArticleId></ArticleIdList></Reference><Reference><Citation>Koulakoff A., Mei X., Orellana J.A., Saez J.C., Giaume C. Glial connexin expression and function in the context of Alzheimer&#x2019;s disease. Biochim. Biophys. Acta. 2012;1818:2048&#x2013;2057. doi: 10.1016/j.bbamem.2011.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2011.10.001</ArticleId><ArticleId IdType="pubmed">22008509</ArticleId></ArticleIdList></Reference><Reference><Citation>Charron G., Doudnikoff E., Canron M.H., Li Q., Vega C., Marais S., Baufreton J., Vital A., Oliet S.H., Bezard E. Astrocytosis in parkinsonism: Considering tripartite striatal synapses in physiopathology? Front Aging Neurosci. 2014;6:258. doi: 10.3389/fnagi.2014.00258.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2014.00258</ArticleId><ArticleId IdType="pmc">PMC4174038</ArticleId><ArticleId IdType="pubmed">25309435</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita A., Yamaguchi H., Yamasaki R., Cui Y., Matsuoka Y., Yamada K.I., Kira J.I. Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson&#x2019;s disease animal model. J. Neuroinflamm. 2018;15:227. doi: 10.1186/s12974-018-1251-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1251-0</ArticleId><ArticleId IdType="pmc">PMC6090688</ArticleId><ArticleId IdType="pubmed">30103794</ArticleId></ArticleIdList></Reference><Reference><Citation>Masaki K., Suzuki S.O., Matsushita T., Yonekawa T., Matsuoka T., Isobe N., Motomura K., Wu X.M., Tabira T., Iwaki T., et al. Extensive loss of connexins in Balo&#x2019;s disease: Evidence for an auto-antibody-independent astrocytopathy via impaired astrocyte-oligodendrocyte/myelin interaction. Acta Neuropathol. 2012;123:887&#x2013;900. doi: 10.1007/s00401-012-0972-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-0972-x</ArticleId><ArticleId IdType="pubmed">22438105</ArticleId></ArticleIdList></Reference><Reference><Citation>Dermietzel R., Traub O., Hwang T.K., Beyer E., Bennett M.V., Spray D.C., Willecke K. Differential expression of three gap junction proteins in developing and mature brain tissues. Proc. Natl. Acad. Sci. USA. 1989;86:10148&#x2013;10152. doi: 10.1073/pnas.86.24.10148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.86.24.10148</ArticleId><ArticleId IdType="pmc">PMC298664</ArticleId><ArticleId IdType="pubmed">2557621</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunzelmann P., Schr&#xf6;der W., Traub O., Steinh&#xe4;user C., Dermietzel R., Willecke K. Late onset and increasing expression of the gap junction protein connexin30 in adult murine brain and long-term cultured astrocytes. Glia. 1999;25:111&#x2013;119. doi: 10.1002/(SICI)1098-1136(19990115)25:2&lt;111::AID-GLIA2&gt;3.0.CO;2-I.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1098-1136(19990115)25:2&lt;111::AID-GLIA2&gt;3.0.CO;2-I</ArticleId><ArticleId IdType="pubmed">9890626</ArticleId></ArticleIdList></Reference><Reference><Citation>Koulakoff A., Ezan P., Giaume C. Neurons control the expression of connexin 30 and connexin 43 in mouse cortical astrocytes. Glia. 2008;56:1299&#x2013;1311. doi: 10.1002/glia.20698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20698</ArticleId><ArticleId IdType="pubmed">18512249</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly J.J., Shao Q., Jagger D.J., Laird D.W. Cx30 exhibits unique characteristics including a long half-life when assembled into gap junctions. J. Cell Sci. 2015;128:3947&#x2013;3960. doi: 10.1242/jcs.174698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.174698</ArticleId><ArticleId IdType="pubmed">26359304</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin M., Anderson P.N., Cook J.E., Green C.R., Becker D.L. Blocking connexin43 expression reduces inflammation and improves functional recovery after spinal cord injury. Mol. Cell Neurosci. 2008;39:152&#x2013;160. doi: 10.1016/j.mcn.2008.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2008.06.005</ArticleId><ArticleId IdType="pubmed">18617007</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M.J., Kress B., Han X., Moll K., Peng W., Ji R.R., Nedergaard M. Astrocytic CX43 hemichannels and gap junctions play a crucial role in development of chronic neuropathic pain following spinal cord injury. Glia. 2012;60:1660&#x2013;1670. doi: 10.1002/glia.22384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22384</ArticleId><ArticleId IdType="pmc">PMC3604747</ArticleId><ArticleId IdType="pubmed">22951907</ArticleId></ArticleIdList></Reference><Reference><Citation>Stout C.E., Costantin J.L., Naus C.C., Charles A.C. Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J. Biol. Chem. 2002;277:10482&#x2013;10488. doi: 10.1074/jbc.M109902200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109902200</ArticleId><ArticleId IdType="pubmed">11790776</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing L., Yang T., Cui S., Chen G. Connexin Hemichannels in Astrocytes: Role in CNS Disorders. Front Mol. Neurosci. 2019;12:23. doi: 10.3389/fnmol.2019.00023.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00023</ArticleId><ArticleId IdType="pmc">PMC6372977</ArticleId><ArticleId IdType="pubmed">30787868</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherian P.P., Siller-Jackson A.J., Gu S., Wang X., Bonewald L.F., Sprague E., Jiang J.X. Mechanical strain opens connexin 43 hemichannels in osteocytes: A novel mechanism for the release of prostaglandin. Mol. Biol. Cell. 2005;16:3100&#x2013;3106. doi: 10.1091/mbc.e04-10-0912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e04-10-0912</ArticleId><ArticleId IdType="pmc">PMC1165395</ArticleId><ArticleId IdType="pubmed">15843434</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruzzone S., Guida L., Zocchi E., Franco L., De Flora A. Connexin 43 hemi channels mediate Ca2+-regulated transmembrane NAD+ fluxes in intact cells. Faseb J. 2001;15:10&#x2013;12. doi: 10.1096/fj.00-0566fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.00-0566fje</ArticleId><ArticleId IdType="pubmed">11099492</ArticleId></ArticleIdList></Reference><Reference><Citation>Harcha P.A., Garces P., Arredondo C., Fernandez G., Saez J.C., van Zundert B. Mast Cell and Astrocyte Hemichannels and Their Role in Alzheimer&#x2019;s Disease, ALS, and Harmful Stress Conditions. Int. J. Mol. Sci. 2021;22:1924. doi: 10.3390/ijms22041924.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22041924</ArticleId><ArticleId IdType="pmc">PMC7919494</ArticleId><ArticleId IdType="pubmed">33672031</ArticleId></ArticleIdList></Reference><Reference><Citation>Valori C.F., Brambilla L., Martorana F., Rossi D. The multifaceted role of glial cells in amyotrophic lateral sclerosis. Cell Mol. Life Sci. 2014;71:287&#x2013;297. doi: 10.1007/s00018-013-1429-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1429-7</ArticleId><ArticleId IdType="pubmed">23912896</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaz S.H., Pinto S., Sebasti&#xe3;o A.M., Brites D. Astrocytes in Amyotrophic Lateral Sclerosis. In: Araki T., editor. Amyotrophic Lateral Sclerosis. Exon Publications; Brisbane, Australia: 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">34473439</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasabe J., Miyoshi Y., Suzuki M., Mita M., Konno R., Matsuoka M., Hamase K., Aiso S. D-amino acid oxidase controls motoneuron degeneration through D-serine. Proc. Natl. Acad. Sci. USA. 2012;109:627&#x2013;632. doi: 10.1073/pnas.1114639109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1114639109</ArticleId><ArticleId IdType="pmc">PMC3258611</ArticleId><ArticleId IdType="pubmed">22203986</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S., Miranda C.J., Braun L., Meyer K., Frakes A.E., Ferraiuolo L., Likhite S., Bevan A.K., Foust K.D., McConnell M.J., et al. Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis. Nat. Med. 2016;22:397&#x2013;403. doi: 10.1038/nm.4052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4052</ArticleId><ArticleId IdType="pmc">PMC4823173</ArticleId><ArticleId IdType="pubmed">26928464</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben Haim L., Carrillo-de Sauvage M.A., Ceyzeriat K., Escartin C. Elusive roles for reactive astrocytes in neurodegenerative diseases. Front Cell Neurosci. 2015;9:278. doi: 10.3389/fncel.2015.00278.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00278</ArticleId><ArticleId IdType="pmc">PMC4522610</ArticleId><ArticleId IdType="pubmed">26283915</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepore A.C., O&#x2019;Donnell J., Kim A.S., Williams T., Tuteja A., Rao M.S., Kelley L.L., Campanelli J.T., Maragakis N.J. Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS. PLoS ONE. 2011;6:e25968. doi: 10.1371/journal.pone.0025968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025968</ArticleId><ArticleId IdType="pmc">PMC3187829</ArticleId><ArticleId IdType="pubmed">21998733</ArticleId></ArticleIdList></Reference><Reference><Citation>Dere E., De Souza-Silva M.A., Frisch C., Teubner B., Sohl G., Willecke K., Huston J.P. Connexin30-deficient mice show increased emotionality and decreased rearing activity in the open-field along with neurochemical changes. Eur. J. Neurosci. 2003;18:629&#x2013;638. doi: 10.1046/j.1460-9568.2003.02784.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1460-9568.2003.02784.x</ArticleId><ArticleId IdType="pubmed">12911759</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaki H. Guidelines for Proper Conduct of Animal Experiments by the Science Council of Japan. Altern. Anim. Test. Exp. 2020;25:72.</Citation></Reference><Reference><Citation>Boutron I., Percie du Sert N., Ahluwalia A., Alam S., Avey M.T., Baker M., Browne W.J., Clark A., Cuthill I.C., Dirnagl U., et al. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol. 2020;18:183&#x2013;188. doi: 10.1371/journal.pbio.3000411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3000411</ArticleId><ArticleId IdType="pmc">PMC7360025</ArticleId><ArticleId IdType="pubmed">32663221</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., Cleveland D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389&#x2013;1392. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahbazian M., Young J., Yuva-Paylor L., Spencer C., Antalffy B., Noebels J., Armstrong D., Paylor R., Zoghbi H. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron. 2002;35:243&#x2013;254. doi: 10.1016/S0896-6273(02)00768-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)00768-7</ArticleId><ArticleId IdType="pubmed">12160743</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiraishi W., Yamasaki R., Hashimoto Y., Ko S., Kobayakawa Y., Isobe N., Matsushita T., Kira J.I. Clearance of peripheral nerve misfolded mutant protein by infiltrated macrophages correlates with motor neuron disease progression. Sci. Rep. 2021;11:16438. doi: 10.1038/s41598-021-96064-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-96064-6</ArticleId><ArticleId IdType="pmc">PMC8360983</ArticleId><ArticleId IdType="pubmed">34385589</ArticleId></ArticleIdList></Reference><Reference><Citation>Monville C., Torres E.M., Dunnett S.B. Comparison of incremental and accelerating protocols of the rotarod test for the assessment of motor deficits in the 6-OHDA model. J. Neurosci. Methods. 2006;158:219&#x2013;223. doi: 10.1016/j.jneumeth.2006.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneumeth.2006.06.001</ArticleId><ArticleId IdType="pubmed">16837051</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatzipetros T., Kidd J.D., Moreno A.J., Thompson K., Gill A., Vieira F.G. A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS. J. Vis. Exp. 2015;104:e53257. doi: 10.3791/53257.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/53257</ArticleId><ArticleId IdType="pmc">PMC4692639</ArticleId><ArticleId IdType="pubmed">26485052</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling K.K., Jackson M., Alkam D., Liu D., Allaire N., Sun C., Kiaei M., McCampbell A., Rigo F. Antisense-mediated reduction of EphA4 in the adult CNS does not improve the function of mice with amyotrophic lateral sclerosis. Neurobiol. Dis. 2018;114:174&#x2013;183. doi: 10.1016/j.nbd.2018.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.03.002</ArticleId><ArticleId IdType="pmc">PMC8820074</ArticleId><ArticleId IdType="pubmed">29518482</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.D., Liu N., Levin S.C., Ottosson L., Andersson U., Harris H.E., Woodruff T.M. Therapeutic blockade of HMGB1 reduces early motor deficits, but not survival in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. J. Neuroinflamm. 2019;16:45. doi: 10.1186/s12974-019-1435-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1435-2</ArticleId><ArticleId IdType="pmc">PMC6380064</ArticleId><ArticleId IdType="pubmed">30782181</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulino R., Vicario N., Giunta M.A.S., Spoto G., Calabrese G., Vecchio M., Gulisano M., Leanza G., Parenti R. Neuromuscular Plasticity in a Mouse Neurotoxic Model of Spinal Motoneuronal Loss. Int. J. Mol. Sci. 2019;20:1500. doi: 10.3390/ijms20061500.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20061500</ArticleId><ArticleId IdType="pmc">PMC6471664</ArticleId><ArticleId IdType="pubmed">30917493</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19:185&#x2013;193. doi: 10.1093/bioinformatics/19.2.185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/19.2.185</ArticleId><ArticleId IdType="pubmed">12538238</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., Ellis B., Gautier L., Ge Y., Gentry J., et al. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80. doi: 10.1186/gb-2004-5-10-r80.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2004-5-10-r80</ArticleId><ArticleId IdType="pmc">PMC545600</ArticleId><ArticleId IdType="pubmed">15461798</ArticleId></ArticleIdList></Reference><Reference><Citation>Quackenbush J. Microarray data normalization and transformation. Nat. Genet. 2002;32:496&#x2013;501. doi: 10.1038/ng1032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1032</ArticleId><ArticleId IdType="pubmed">12454644</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>